 Recurrent condylomata acuminata recombinant interferon multicenter double-blind placebo-controlled clinical trial Condylomata International Collaborative Study Group Systemic interferon effective therapy recurrent genital warts double-blind placebo-controlled international trial patients recurrent condylomata systemic interferon doses MIU times week weeks treatment period treatment-free follow-up period months Complete responders month months recurrence combined rates complete response total disappearance lesions appearance new ones major incomplete response reduction total lesion area months commencement therapy patients MIU interferon placebo recurrence rates end months placebo groups group systemic interferon times weeks doses MIU effective monotherapy genital warts standard ablative therapy